These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2048242)
21. [Treatment of Parkinson syndrome in general practice]. Ferel D Schweiz Rundsch Med Prax; 1972 Oct; 61(40):1237-40. PubMed ID: 5084594 [No Abstract] [Full Text] [Related]
22. [Treatment of the Parkinson syndrome with amantadine]. Hartmann-von Monakow K Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093 [No Abstract] [Full Text] [Related]
23. Parkinson's disease. Refining and advancing treatment. Mayo Clin Health Lett; 2007 Nov; 25(11):1-3. PubMed ID: 18232067 [No Abstract] [Full Text] [Related]
24. Parkinson's disease. A holistic approach. Barker S; Grant A; Hodnicki DR Am J Nurs; 1998 Nov; 98(11):48A-48G; quiz 48G-48H. PubMed ID: 9826936 [No Abstract] [Full Text] [Related]
26. Steady your sights on Parkinson's disease. Chadwick C Nursing; 2008 Dec; 38(12):56hn1-2, 56hn4. PubMed ID: 19047849 [No Abstract] [Full Text] [Related]
27. Amantadine hydrochloride in treatment of Parkinsonism. Nagaswami S; Nagaswami R Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280 [No Abstract] [Full Text] [Related]
28. [The origin of Parkinson's disease]. Rinne J Duodecim; 1997; 113(18):1819-24. PubMed ID: 10892075 [No Abstract] [Full Text] [Related]
29. [Mechanisms and treatments of Parkinson disease]. Pollak P Rev Prat; 1997 May; 47(10):1068-76. PubMed ID: 9208669 [TBL] [Abstract][Full Text] [Related]
30. [Parkinson disease therapy: how great is the progress? Possibilities, limitations and future prospects?]. Schulz-Hanke I Dtsch Med Wochenschr; 2003 Dec; 128(51-52):2689-90. PubMed ID: 14725284 [No Abstract] [Full Text] [Related]
31. Selegiline as neuroprotective therapy in Parkinson's disease: concepts and controversies. Langston JW Neurology; 1990 Oct; 40(10 Suppl 3):suppl 61-6; discussion 67-9. PubMed ID: 2120617 [No Abstract] [Full Text] [Related]
37. Treatment should not be initiated too soon in Parkinson's disease. Aminoff MJ Ann Neurol; 2006 Mar; 59(3):562-4; discussion 564-5. PubMed ID: 16489613 [No Abstract] [Full Text] [Related]
38. Parkinson's disease. Clarke C; Moore A Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943 [No Abstract] [Full Text] [Related]
39. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Montgomery EB Neurology; 2007 Jan; 68(2):164; author reply 164. PubMed ID: 17210906 [No Abstract] [Full Text] [Related]
40. Your CE topic this month (No. 15). Therapy for Parkinson's disease. Bergman D J Pract Nurs; 1986 Jun; 36(2):18-25. PubMed ID: 3636400 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]